[Interventional therapy indications in the elderly - are they different?]

Area of Science:

• Cardiology
• Geriatric Medicine
• Interventional Cardiology

Background:

• Cardiovascular disease (CVD) prevalence increases with age, posing a significant health burden in adults over 75.
• Many clinical trials have historically excluded older populations, leading to limited evidence for their specific treatment needs.
• Existing data primarily relies on subgroup analyses and registries, highlighting a gap in robust randomized trial evidence for elderly CVD patients.

Purpose of the Study:

• To review the current understanding of cardiovascular disease management in elderly patients.
• To discuss the indications, risks, and outcomes of interventions in older adults with cardiovascular disease.
• To emphasize the need for dedicated randomized trials focusing on the geriatric population.

Main Methods:

• Review of existing literature, subgroup analyses, and registry data concerning cardiovascular disease interventions in elderly patients.
• Comparison of outcomes between Coronary Artery Bypass Graft surgery (CABG) and Percutaneous Coronary Intervention (PCI).
• Evaluation of invasive versus conservative treatment strategies for acute coronary syndrome (ACS) in the elderly.

Main Results:

• Indications for revascularization in the elderly are generally similar to younger patients, but comorbidities and functional status necessitate individualized decisions.
• Older patients face higher risks of complex coronary anatomy and procedural complications.
• Long-term mortality is comparable between CABG and PCI, though PCI may require higher rates of re-intervention.

Conclusions:

• An invasive approach is superior to conservative management for elderly patients presenting with acute coronary syndrome, even those with multiple comorbidities.
• While long-term mortality outcomes are similar between surgical and interventional revascularization, procedural considerations differ.
• There is a critical need for large-scale randomized trials specifically designed to include and evaluate older patients with cardiovascular disease.